Authors: Filippo Patti1, Giulia Marvaso2, Matteo Pepa1, Barbara Vischioni3, Mattia Zaffaroni4, Stefania Comi5, Dario Zerini4, Matteo Augugliaro4, Stefania Russo3, Francesca Valvo6, Tommaso Giandini7, Barbara Avuzzi8, Riccardo Valdagni9, Ottavio De Cobelli10, Federica Cattani5, Ester Orlandi3, Barbara Alicja Jereczek-Fossa11, Roberto Orecchia12
1IEO - European Institute of Oncology IRCCS, Division of Radiotherapy, Milan, Italy; 2Department of Oncology and Hemato-Oncology, University of Milan; IEO - European Institute of Oncology IRCCS, Division of Radiotherapy, Milan, Italy; 3National Center for Oncological Hadrontherapy (CNAO), Clinical Department, Pavia, Italy; 4IEO - European Institute of Oncology, Division of Radiotherapy, Milan, Italy; 5IEO - European Institute of Oncology, Medical Physics Unit, Milan, Italy; 6National Center for Oncological Hadronterapy (CNAO), Clinical Department, Pavia, Italy; 7Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Medical Physics, Milan, Italy; 8Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Radiation Oncology 1, Milan, Italy; 9Department of Oncology and Hemato-Oncology - University of Milan; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Radiation Oncology 1, Milan, Italy; 10Department of Oncology and Hemato-Oncology, University of Milan; IEO - European Institute of Oncology IRCCS, Division of Urology, Milan, Italy; 11D epartment of Oncology and Hemato-Oncology, University of Milan; IEO - European Institute of Oncology IRCCS, Division of Radiotherapy, Milan, Italy; 12IEO - European Institute of Oncology IRCCS, Scientific Directorate, Milan, Italy
Show Affiliations
Hide Affiliations